Enjoy complimentary customisation on priority with our Enterprise License!
The human liver models market share is expected to increase by USD 1.91 billion from 2021 to 2026, at a CAGR of 12.94%.
This human liver models market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers human liver models market segmentation by type (liver organoids, liver-on-a-chip, 2D models, and 3D bioprinting) and geography (North America, Europe, APAC, Middle East and Africa, and South America). The human liver models market report also offers information on several market vendors, including BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical among others.
Download the Free Report Sample to Unlock the Human Liver Models Market Size for the Forecast Period and Other Important Statistics
The increasing prevalence of liver diseases is notably driving the human liver models market growth, although factors such as lack of adequate healthcare infrastructure in developing nations may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the human liver models industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Human Liver Models Market Driver
One of the key factors driving growth in the human liver models market is the increasing prevalence of liver diseases. Liver cancer is among the leading causes of cancer-related deaths globally. The increase in the incidence of risk factors like hepatitis B and C and underlying cirrhosis will lead to the rise in the risk of liver cancer depending on the etiology. The increase in the incidence of lifestyle diseases like fatty liver is a major risk factor for liver cancer. Long-term alcohol consumption is also the primary reason for the increase in the incidence of liver cancer. Furthermore, the increase in the incidence of new risk factors such as diabetes, obesity, and related non-alcoholic fatty liver disease may also be associated with the increase in the incidence of liver diseases. The current disease management for liver diseases is the same for all patients with different etiologies. Advances in disease management and R and D for the causative factors may reduce the incidence of liver cancer, which will increase the application of human liver models.
Key Human Liver Models Market Trend
The technological advancements in the human organ model is another factor supporting the human liver models market share growth. 3D tissue and organ models can better represent the spatial and biological complexity of living tissues, enable a more accurate assessment of therapeutic efficacy and safety, and decrease the cost of drug discovery. Thus, it will provide an effective alternative to traditional 2D cell culture and animal models. Therefore, human cells-based 3D tissue and organ models have recently emerged as robust platforms, which can facilitate tissue regeneration, organ transplantation and repair, drug discovery, toxicological screening, as well as in vitro disease modeling in both basic and clinical research. Various powerful techniques have been developed for 3D tissue and organ models, including organoid culture, 3D bioprinting, microfluidics, organs on chips, functional biomaterials for tissue engineering, and so forth. Thus, the growing technological advancements in the human organ model will positively impact the market in focus.
Key Human Liver Models Market Challenge
The lack of adequate healthcare infrastructure in developing nations will be a major challenge for the human liver models market during the forecast period. In underdeveloped and developing economies such as India, Argentina, and African countries, there is a lack of adequate healthcare infrastructure due to limited healthcare expenditure. This is one of the major factors restraining the adoption of treatment in countries such as India, Brazil, and South Africa. Only a limited number of healthcare institutions in underdeveloped and developing countries can use advanced radiotherapy systems for cancer treatment. This limits the number of radiotherapy and chemotherapy procedures despite their high demand. Thus, the lack of infrastructure and inadequate expenditure in the healthcare sector are expected to hinder the adoption of human liver models, which, in turn, will negatively impact the growth of the market.
This human liver models market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global human liver models market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the human liver models market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the human liver models market encompasses successful business strategies deployed by the key vendors. The human liver models market is fragmented and the vendors are deploying growth strategies such as acquiring and forming mergers with other vendors to increase their market share to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The human liver models market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the human liver models market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
35% of the market's growth will originate from North America during the forecast period. The US is the key market for human liver models in North America. Market growth in this region will be slower than the growth of the market in other regions.
Considerable investments in the pharmaceutical industry, specifically the oncology sector, and the presence of pharmaceutical giants in the region will facilitate the human liver models market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 negatively impacted the economies of various countries in the region. Governments of various countries such as the US, Canada, and others in the region imposed a nationwide lockdown, which limited the movement of people. In the first half of 2021, with the gradual decrease in the number of COVID-19 cases, lockdowns were lifted, leading to the reopening of healthcare facilities and clinics. This has led to the resumption of regular operations and checkups for cancer patients. Such factors are expected to positively impact the demand for liver cancer drugs, which, in turn, will drive the market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The human liver models market share growth by the liver organoids segment will be significant during the forecast period. The increasing need for diagnosis of liver disease owing to the need for R and D and drug development is expected to drive the growth of the segment, which, in turn, will drive the market during the forecast period. In recent years, liver diseases have been one of the most common pathologies in the digestive system and have a high incidence. Also, the incidence of liver diseases has gradually increased owing to drinking, obesity, viral which include hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and other reasons.
This report provides an accurate prediction of the contribution of all the segments to the growth of the human liver models market size and actionable market insights on post COVID-19 impact on each segment.
Human Organoids market - The market share is expected to increase to USD 1.18 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.9%.
Human Liver Models Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Decelerate at a CAGR of 12.94% |
Market growth 2022-2026 |
$ 1.91 billion |
Market structure |
Fragmented |
YoY growth (%) |
16.76 |
Regional analysis |
North America, Europe, APAC, Middle East and Africa, and South America |
Performing market contribution |
North America at 35% |
Key consumer countries |
US, China, Japan, Germany, and UK |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
BioIVT LLC, CELLINK AB, CN Bio Innovations Ltd., Corning Inc., Cyfuse Biomedical K.K., Emulate Inc., H. L. Scientific, Hangzhou Jienuofei Biotechnology Co. Ltd., InSphero AG, Kirkstall Ltd., LifeSpan BioSciences Inc., MIMETAS BV, N. C. KANSIL and SONS, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and Western Surgical |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.